08 APR 2019

Access to Medical Cannabis

Sarah Wollaston Chair, Health and Social Care Committee, Chair, Liaison Committee (Commons), Chair, Liaison Committee

I warmly welcome the measures announced by the Secretary of State today, but will he go further in discussing the importance of clinical trials and answer some of the many questions about striking the right balance between THC and CBD? We have heard in the Select Committee that some pharmaceutical companies are refusing to make their products available for clinical trials. Will he look specifically at that point? We need to ensure that safe and consistent products are regularly available and that they are of a predictable pharmaceutical grade, as we have heard.


Matthew Hancock Secretary of State for Health and Social Care

If I may, Mr Speaker, I would like to add to my previous answer by congratulating my hon. Friend the Member for Watford, the former Business Minister, on all that he did to support business, enterprise and the case for capitalism while he was in his former job. I regret his departing from the Government, because he was a brilliant Minister.

On the question ahead of me, so to speak, the Chair of the Select Committee, Dr Wollaston, is right to say that it is vital to bring forward these clinical trials, and that the pharmaceutical companies that provide the oils have not pushed forward the trials in the way that would normally happen. We have therefore stepped in to try to make them happen, but we do need the calls to be answered.

They Work For You

Download this as a PDF

Back to all posts

Public Whip


If you would like to view my voting record it can be seen on the Public Whip's website, but you need to see how this information is compiled as it can sometimes be misleading.

What is on in Parliament

If you would like to see full details of what's on in Parliament this week, you can do so via the Parliament website.


This will take you to all of my written and spoken material by date